INNATE PHARMA SA (IDD.DE) Forecast, Price Target & Analyst Ratings

FRA:IDD • FR0010331421

Current stock price

1.13 EUR
+0.04 (+4.05%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INNATE PHARMA SA (IDD.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€5.58
+ 393.69% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q3 / 2025
EPS Estimate
-€0.12
Revenue Estimate
1.98M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€5.58
Upside
+ 393.69%
From current price of €1.13 to mean target of €5.58, Based on 8 analyst forecasts
Low
€2.30
Median
€6.41
High
€7.39

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for IDD.DE. The average price target is 5.58 EUR. This implies a price increase of 393.69% is expected in the next year compared to the current price of 1.13.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IDD Current Analyst RatingIDD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

IDD Historical Analyst RatingsIDD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
IDD.DE was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IDD.DE.
In the previous month the buy percentage consensus was at a similar level.
IDD.DE was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q3 / 2025
EPS Estimate
-€0.12
Revenue Estimate
1.98M
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
2

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

IDD.DE is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.12 EUR and the consensus revenue estimate is 1.98M EUR.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IDD.DE revenue by date.IDD.DE revenue by date.
49.58M
309.35%		51.901M
4.68%		12.622M
-75.68%		25.818M
104.55%		25.319M
-1.93%		15.809M
-37.56%		64.861M
310.28%		195.72M
201.75%		172.79M
-11.72%		224.02M
29.65%		263.64M
17.69%		440.9M
67.24%
EBITDA
YoY % growth
IDD.DE ebitda by date.IDD.DE ebitda by date.
28.98M
167.04%		-7.578M
-126.15%		-49.581M
-554.28%		27.27M
155.00%		144.43M
429.63%		192.91M
33.57%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IDD.DE ebit by date.IDD.DE ebit by date.
-16.425M
65.66%		-12.669M
22.87%		-51.575M
-307.10%		-15.288M
70.36%		34.614M
326.41%		-61.384M
-277.34%		-65.419M
-6.57%		42.009M
164.22%		65.393M
55.66%		105.74M
61.70%		134.71M
27.40%		N/A
Operating Margin
IDD.DE operating margin by date.IDD.DE operating margin by date.
-33.13%-24.41%-408.61%-59.21%136.71%-388.28%-100.86%21.46%37.85%47.20%51.10%N/A
EPS
YoY % growth
IDD.DE eps by date.IDD.DE eps by date.
N/A
72.93%		N/A
-169.82%		N/A
23.22%		-0.56
-35.80%		-0.50
10.00%		-0.69
-38.38%		N/AN/AN/AN/AN/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.12-0.12-0.12
-9.09%		-0.07
72.00%		-0.13
-8.33%		-0.10
16.67%		-0.13
-8.33%		-0.13
-85.71%		-0.09
30.77%		-0.13
-30.00%
Revenue
Q2Q % growth		1.98M2.172M
-49.83%		2.222M
-54.35%		7.817M
367.80%		2.293M
15.81%		2.404M
10.68%		2.353M
5.90%		2.788M
-64.33%		9.878M
330.79%		6.989M
190.72%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-12.857M-12.665M
49.86%		-13.019M
-34.83%		-8.211M
67.71%		-13.645M
-6.13%		-16.17M
-27.67%		-19.766M
-51.82%		-19.443M
-136.78%		-14.685M
-7.62%		-19.917M
-23.17%

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IDD.DE Yearly Revenue VS EstimatesIDD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
IDD.DE Yearly EPS VS EstimatesIDD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-19.15%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-22.02%
Revenue Next 5 Year
42.47%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
95.79%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INNATE PHARMA SA / IDD.DE Forecast FAQ

Can you provide the average price target for INNATE PHARMA SA stock?

8 analysts have analysed IDD.DE and the average price target is 5.58 EUR. This implies a price increase of 393.69% is expected in the next year compared to the current price of 1.13.

Can you provide the upcoming earnings date for INNATE PHARMA SA?

INNATE PHARMA SA (IDD.DE) will report earnings on 2026-05-13.

What are the consensus estimates for IDD stock next earnings?

The consensus EPS estimate for the next earnings of INNATE PHARMA SA (IDD.DE) is -0.12 EUR and the consensus revenue estimate is 1.98M EUR.

What is the consensus rating for IDD stock?

The consensus rating for INNATE PHARMA SA (IDD.DE) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.